Core Viewpoint - JD Health reported strong financial performance for Q3 2025, with revenue of 17.12 billion yuan, a year-on-year increase of 28.7%, and a Non-IFRS net profit of 1.9 billion yuan, up 42.4% year-on-year [1] Group 1: Financial Performance - JD Health achieved revenue of 17.12 billion yuan in Q3 2025, reflecting a 28.7% year-on-year growth [1] - The Non-IFRS net profit for the same period was 1.9 billion yuan, representing a 42.4% increase compared to the previous year [1] Group 2: Market Trends and Consumer Behavior - During the 11.11 shopping festival, JD Health's nutrition and health brands saw transaction volumes double year-on-year, with nearly 100 subcategories also experiencing 100% growth [3] - The trend in China's nutrition consumption is shifting from "general health" to "precise nutrition," focusing on specific groups and scenarios, while consumer decision-making is becoming more rational and evidence-based [3] Group 3: Strategic Initiatives - JD Health is leveraging its "global health new product online launch platform" to establish quality barriers and provide brands with efficient access to the Chinese market [3] - The company has formed partnerships with nine global nutrition and health brands during the recent import expo, aiming to introduce high-quality products to the Chinese market [3] Group 4: Service Innovations - JD Health has established a professional nutritionist team to provide scientific nutrition knowledge through live broadcasts and online consultations, addressing consumer decision-making anxiety [4] - The introduction of the "AI Nutritionist" has enabled over 90% of online nutrition consultations during the 11.11 event to be handled by AI, covering over 200 nutrition categories and serving more than 20 million users [4] - The company aims to deepen its supply chain layout and integrate global nutrition products with professional services to drive the health and nutrition industry towards standardization and precision [4]